Literature DB >> 13161503

[The history of the development of H.B.F. 386 actinomycin C Bayer].

H BROCKMANN, A BOHNE, H FRIEDRICH, C HACKMANN.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13161503     DOI： 10.1055/s-0028-1115450

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  4 in total

1.  [Chemotherapy of carcinoma and its experimental principles].

Authors:  H W VASTERLING
Journal:  Arch Gynakol       Date:  1959

2.  [Cytological criteria of sanamycin action; animal experiments].

Authors:  F HECKNER; J HAMM; W EGER
Journal:  Klin Wochenschr       Date:  1957-05-01

3.  [Therapeutic control of systemic diseases, leukemic lymphadenosis, lymphogranulomatosis, mycosis fungoides, so-called reticulosarcomatosis by actinomycin C].

Authors:  C F FUNK; F KROBER
Journal:  Arch Klin Exp Dermatol       Date:  1957

4.  [Experiences in therapy of lymphogranulomatosis with actinomycin C (sanamycin)].

Authors:  H MARTIN
Journal:  Klin Wochenschr       Date:  1954-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.